Breast Cancer

TV star Shannen Doherty discusses some of the rough times she went through during her breast cancer battle.

Focusing on recurrence after a cancer diagnosis can be overwhelming, but it doesn't have to be.

While cancer may be a part of a survivor's identity, there are other aspects, too.

What do these numbers really mean?

When treatments are working, it can be hard for loved ones to understand the divide between appearances and the reality of the diagnosis.

Making our own decisions is empowering after facing the trauma of breast cancer.

With more treatment options than ever, Maura N. Dickler discusses some of the deciding factors for patients with ER positive metastatic breast cancer.

Two-time cancer survivor shares her thoughts about that small, quiet voice.

Ricardo J. Bello, postdoctoral research fellow at Johns Hopkins School of Medicine, discusses the importance of patient education to drive the decision-making process in breast reconstruction and surgery. With more knowledge, they can ask higher level questions and help the field thrive.

New standards were just established for patients undergoing surgery for DCIS.

Our cancer clock never stops ticking, but we can stop looking.

Luke Peppone, assistant professor at the University of Rochester Medical Center, discusses the surprising benefits soybean oil had for patients with breast cancer.

Here are 12 things I learned after hearing the words, "You have cancer."

Halle Moore, medical oncologist at the Cleveland Clinic, discusses fatigue in breast cancer survivors.

Post traumatic stress disorder can occur in women who've experienced the trauma of breast cancer.

This is my wish list for all cancer survivors across all types of cancer who struggle with cancer's emotional isolation.

Though it is a difficult subtype to treat right now, Cynthia Ma is optimistic about emerging treatment options for triple-negative breast cancer.

Barnes discusses discovering the value of inspiration in healing.

Knowing the possible risks for breast cancer is important, and some of them are within our control.

The FDA granted ribociclib a breakthrough therapy designation for some patients with breast cancer.

Breast cancer and melanoma survivor shares time management tips to fellow survivors.

AI therapy can put breast cancer survivors at risk for bone fractures, making bone density monitoring important.

In treating low-risk breast cancer, adding novel agents isn't always necessary, Hope S. Rugo says.

Time is limited and the time for experiences with loved ones is today, writes breast cancer survivor Barbara Tako.

Every day seems to link another food or behavior to my cancer diagnosis. Those endless recommendations sometimes just minimize what I am going through. Am I wrong to say enough is enough?